Amylyx Pharmaceuticals Inc (AMLX)
5.715
+0.08
(+1.33%)
USD |
NASDAQ |
Nov 04, 16:00
5.715
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Market Cap: 389.09M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 389.09M |
| November 01, 2024 | 383.99M |
| October 31, 2024 | 367.65M |
| October 30, 2024 | 358.79M |
| October 29, 2024 | 345.18M |
| October 28, 2024 | 362.88M |
| October 25, 2024 | 361.52M |
| October 24, 2024 | 333.60M |
| October 23, 2024 | 337.69M |
| October 22, 2024 | 308.41M |
| October 21, 2024 | 317.26M |
| October 18, 2024 | 325.43M |
| October 17, 2024 | 266.88M |
| October 16, 2024 | 277.78M |
| October 15, 2024 | 268.24M |
| October 14, 2024 | 243.74M |
| October 11, 2024 | 241.69M |
| October 10, 2024 | 235.57M |
| October 09, 2024 | 230.80M |
| October 08, 2024 | 221.95M |
| October 07, 2024 | 209.69M |
| October 04, 2024 | 212.42M |
| October 03, 2024 | 200.16M |
| October 02, 2024 | 206.29M |
| October 01, 2024 | 208.33M |
| Date | Value |
|---|---|
| September 30, 2024 | 220.59M |
| September 27, 2024 | 209.69M |
| September 26, 2024 | 217.86M |
| September 25, 2024 | 212.42M |
| September 24, 2024 | 204.93M |
| September 23, 2024 | 198.12M |
| September 20, 2024 | 211.06M |
| September 19, 2024 | 196.08M |
| September 18, 2024 | 196.08M |
| September 17, 2024 | 198.80M |
| September 16, 2024 | 180.42M |
| September 13, 2024 | 178.38M |
| September 12, 2024 | 169.53M |
| September 11, 2024 | 174.97M |
| September 10, 2024 | 181.10M |
| September 09, 2024 | 171.57M |
| September 06, 2024 | 161.36M |
| September 05, 2024 | 149.78M |
| September 04, 2024 | 142.29M |
| September 03, 2024 | 147.06M |
| August 30, 2024 | 151.14M |
| August 29, 2024 | 144.33M |
| August 28, 2024 | 142.29M |
| August 27, 2024 | 145.02M |
| August 26, 2024 | 150.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
110.17M
Minimum
Jun 18 2024
2.722B
Maximum
Jan 27 2023
1.185B
Average
1.201B
Median
Market Cap Benchmarks
| PTC Therapeutics Inc | 3.107B |
| NovaBay Pharmaceuticals Inc | 3.694M |
| Palatin Technologies Inc | 23.26M |
| iBio Inc | 23.06M |
| Theriva Biologics Inc | 2.081M |
Market Cap Related Metrics
| PS Ratio | 1.316 |
| PEG Ratio | -0.0239 |
| Price to Book Value | 1.489 |
| Price | 5.715 |
| Earnings Yield | -42.87% |
| PEGY Ratio | -0.0239 |